Search results
Results from the WOW.Com Content Network
After sustaining an uptrend on the markets since bottoming in February, GlaxoSmithKline (NYSE:GSK) still has an attractive profile for income and value investors. The stock’s rock-solid dividend ...
The 66 companies that made the cut for the 2025 S&P 500 Dividend Aristocrats list have increased dividends (not just remained the same) for at least 25 years straight. But the requirements go even ...
Best of all, AT&T's shares can be had for only about 10 times its forecasted free cash flow for 2025 (and 9 times its projections for 2027). Additionally, its stock currently yields a hefty 4.9% ...
High-yield dividend stocks may not appeal to some investors. Three Motley Fool contributors have identified some especially great high-yield dividend stocks to buy in 2025 -- and all of them are ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
Dividend Champions have increased their dividend payouts for at least 25 consecutive years, and these five have perhaps the best upside potential in 2025. 5 Blue Chip Dividend Champions With ...
Extremely high yields can be dangerous to your portfolio. However, there is a sweet spot with proven winners yielding 6% to 8%. These companies offer that, and they increase the dividend every year.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...